Trial Profile
Effect of oral trifluridine-tipiracil (TAS-102)-induced neutropenia on survival of patients with advanced/recurrent colorectal cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2018
Price :
$35
*
At a glance
- Drugs Tipiracil/trifluridine (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 06 Sep 2018 New trial record